Characteristic | f (%) | General indicators | Clinical indicators | PC needs | ||||
---|---|---|---|---|---|---|---|---|
Score ≥ 2 f (%) | Score ≤ 1 f (%) | Score ≥ 1 f (%) | Score 0 f (%) | Yes f (%) | No f (%) | p-Value | ||
Sex | ||||||||
Male | 52 (41.9%) | 46 (46.9%) | 6 (23.1%) | 32 (40.0%) | 20 (45.4%) | 31 (40.8%) | 21 (43.7%) | 0.745 |
Female | 72 (58.1%) | 52 (53.1%) | 20 (76.9%) | 48 (60.0%) | 24 (54.6%) | 45 (59.2%) | 27 (56.3%) | |
Age | ||||||||
< 60 years | 94 (75.8%) | 74 (74.0%) | 20 (83.3%) | 53 (72.6%) | 41 (80.3%) | 56 (73.7%) | 38 (79.2%) | 0.487 |
≥ 60 years | 30 (24.2%) | 26 (26.0%) | 4 (16.7%) | 20 (27.4%) | 10 (19.7%) | 20 (26.3%) | 10 (20.8%) | |
Type of disease | ||||||||
Cancer | 89 (71.8%) | 68 (68.0%) | 21 (87.5%) | 49 (67.1%) | 40 (78.4%) | 51 (67.1%) | 38 (79.2%) | 0.146 |
Non cancer | 35 (28.2%) | 32 (32.0%) | 3 (12.5%) | 24 (32.9%) | 11 (21.6%) | 25 (32.9%) | 10 (20.8%) | |
Duration of illness | ||||||||
< 6 months | 17 (13.7%) | 10 (10.2%) | 7 (26.9%) | 7 (8.7%) | 10 (22.7%) | 6 (7.8%) | 11 (22.9%) | 0.018* |
≥ 6 months | 107 (86.3%) | 88 (89.8%) | 19 (73.1%) | 73 (91.3%) | 34 (77.3%) | 70 (92.2%) | 37 (77.1%) |